Abstract:Chronic exposure to inducers of DNA base oxidation and single and double strand breaks contribute to tumorigenesis. In addition to the genetic changes caused by this DNA damage, such tumors often contain epigenetically silenced genes with aberrant promoter region CpG island DNA hypermethylation. We herein explore the relationships between such DNA damage and epigenetic gene silencing using an experimental model in which we induce a defined double strand break in an exogenous promoter construct of the E-cadherin CpG island, which is frequently aberrantly DNA hypermethylated in epithelial cancers. Following the onset of repair of the break, we observe recruitment to the site of damage of key proteins involved in establishing and maintaining transcriptional repression, namely SIRT1, EZH2, DNMT1, and DNMT3B, and the appearance of the silencing histone modifications, hypoacetyl H4K16, H3K9me2 and me3, and H3K27me3. Although in most cells selected after the break, DNA repair occurs faithfully with preservation of activity of the promoter, a small percentage of the plated cells demonstrate induction of heritable silencing. The chromatin around the break site in such a silent clone is enriched for most of the above silent chromatin proteins and histone marks, and the region harbors the appearance of increasing DNA methylation in the CpG island of the promoter. During the acute break, SIRT1 appears to be required for the transient recruitment of DNMT3B and subsequent methylation of the promoter in the silent clones. Taken together, our data suggest that normal repair of a DNA break can occasionally cause heritable silencing of a CpG island-containing promoter by recruitment of proteins involved in silencing. Furthermore, with contribution of the stress-related protein SIRT1, the break can lead to the onset of aberrant CpG island DNA methylation, which is frequently associated with tight gene silencing in cancer.

Double Strand Breaks Can Initiate Gene Silencing and SIRT1-Dependent Onset of DNA Methylation in an Exogenous Promoter CpG Island

PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage

Targeted intragenic demethylation initiates chromatin rewiring for gene activation

8-Chloro-adenosine-induced H3K79me2 Promotes Transcriptional Activation of NBS1 and P21 Genes in Response to DNA Double-stranded Breaks

DNA Double-Strand Breaks Promote Methylation of Histone H3 on Lysine 9 and Transient Formation of Repressive Chromatin

Anthracyclines Induce Double-Strand DNA Breaks at Active Gene Promoters

DNA methylation, its mediators and genome integrity.

Data from Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer

Nucleoporins cooperate with Polycomb silencers to promote transcriptional repression and repair at DNA double strand breaks

Traffic light at DSB–transit regulation between gene transcription and DNA repair

Epigenetic Inactivation of Betaig-h3 Gene in Human Cancer Cells.

Molecular Mechanisms Of A Disease Susceptibility Variant Of Sirt1: Genotoxic Stress-Induced, Ctcf-Dependent Activation Of Sirt1 Gene Expression

Treatment of Breast Cancer Cells with DNA Demethylating Agents Leads to a Release of Pol II Stalling at Genes with DNA-hypermethylated Regions Upstream of TSS.

A positive feedback loop of SIRT1 and miR17HG promotes the repair of DNA double-stranded breaks

Distinct Effects on Gene Expression of Chemical and Genetic Manipulation of the Cancer Epigenome Revealed by a Multimodality Approach

Oxidative stress-mediated epigenetic regulation by G-quadruplexes

TET1 Modulates H4K16 Acetylation by Interacting with hMOF to Regulate Expression of DNA Repair Genes and Oncogenic Transformation

Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.

DNA nicks induce mutational signatures associated with BRCA1 deficiency

Neuronal enhancers are hotspots for DNA single-strand break repair

Global DNA Hypomethylation Coupled to Repressive Chromatin Domain Formation and Gene Silencing in Breast Cancer.